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ease. There is clear evidence that the human immune system crit-
ically determines the outcome of infection and it is widely
accepted that chronic evolution of hepatitis C is associated with
an ineffective adaptive immune response. However, emerging
data suggest that the innate immune system may also play a role.
Natural killer (NK) cells, a heterogeneous sub-population of
lymphocytes, represent a central part of the innate immune sys-
tem. NK cells have a strong cytotoxic potential and are able to
rapidly attack target cells without prior immunization. Moreover,
NK cells secrete cytokines including IFN-c and TNF-a and can
cross-talk with other immuno-competent cells such as dendritic
cells. Thus, NK cells are also involved in the regulation of adaptive
immune responses [1].
Based on the expression of CD56 human NK cells have been
divided into two different functional subsets. In humans, the vast
majority of circulating NK cells belong to the CD56Dim subset,
which is characterized by moderate to high expression levels of
FccRIIIA (CD16) and perforin, as well as having a high cytotoxic
capability. CD56Bright NK cells, in contrast, display rather poor
cytolytic activity, and are considered to function as immuno-
regulatory cells via secretion of cytokines [1].
Of note, NK cells are enriched in the liver. In contrast to the
peripheral blood that contains about 5–10%NK cells, intra-hepatic
lymphocytes contain about 30% NK cells and the percentage of NK
cells in the liver may increase >50% in hepatic diseases [2]. Thus,
NK cells are not only in the right location but also display the
functional capacity needed to control a hepatotropic virus such
as HCV.
Accordingly, immunogenetic analyses suggest that NK cells
may inﬂuence the outcome of acute HCV infection as well as
immuno-pathogenesis in chronic hepatitis C [3,4] and in vitro
studies indicate that NK cells have the potential to recognize
and kill HCV-infected hepatocytes in vivo [5].Journal of Hepatology 20
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receptor.The exact role of NK cells in HCV infection, however, remains
elusive as current studies have yielded inconsistent results
regarding phenotype and function of natural killer cells [6–10].
In addition, little is known regarding the role of NK cells in acute
hepatitis as only a few studies addressed this question.
In the current issue of the Journal of Hepatology, Alter and co-
workers add another piece to the puzzle [11]. Analyzing the phe-
notype and function of NK cells during various stages of HCV
infection with different clinical outcomes, they showed that acute
hepatitis C is associated with an expansion of NK cells which
resembles recent ﬁndings in humans infected with hanta-virus
[12]. Moreover, the authors observed a reduction in the CD56Dim
NK cell subset in acute HCV patients compared to healthy controls
and similar results have been reported previously [13,14]. In con-
trast, acute Puumala hantavirus infection has been shown to be
associated with a rapid expansion of CD56Dim NK cells [12],
underpinning key differences in NK cell responses during acute
infection with different viruses in humans.
Whether low frequency of the CD56Dim subset in acute hepa-
titis C is the result of reduced survival or altered compartmental-
ization of this NK cell subpopulation remains unclear at the
moment.
However, Alter and co-workers show that distribution of NK
cells subsets in resolvers did not differ signiﬁcantly from that
seen in patients with acute or chronic infection [11]. Therefore,
percentages of CD56Bright, CD56Dim, and CD56Neg in the bulk NK
cell population seemed not to inﬂuence the outcome of the
infection.
The function of NK cells is tightly regulated by a balance
between signals delivered by activating and inhibitory NK cell
receptors. Speciﬁc NK cell activation receptors have been shown
to play a role in the control of viral infections [15,16]. Studies on
NK cell receptor expression in chronic hepatitis C have yielded
conﬂicting results. While most groups reported up-regulated
expression of the inhibitory NKG2A receptors, data regarding
NK cell activation receptors NKp30, NKp46, and NKG2D are con-
troversial [7–10].
Alter et al. observed chronic hepatitis C to be associated with a
decline in the proportions of NKp30- and NKp46-expressing NK
cells but expansion of NKG2A-positive NK cells. Interestingly,
they also showed that increased levels of NKG2A+ NK cells and
reduced percentages of NKG2D+, NKp30+ and NKp46+ NK cells
could already be detected in patients with acute HCV infection.11 vol. 55 j 265–267
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In line with two recent reports [13,14], these data clearly indicate
that signiﬁcant alterations of NK cell receptor expression already
occur early in HCV infection and are maintained throughout
chronic HCV infection.
Interestingly, functional experiments demonstrated increased
cytotoxic activity and IFN-c production of circulating NK cells in
patients with acute hepatitis C, indicating that an early impair-
ment of peripheral NK cell function is unlikely to play a major
role in the development of chronic HCV infection.Do NK cells contribute to clearance of HCV infection?
Recent studies failed to reveal any signiﬁcant association
between phenotype/functional activity of NK cells in the acute
phase and outcome of infection [13,14], which would suggest
that NK cells may have little effect and/or rather indirectly affect
anti-HCV immunity.
However, these studies were limited by a rather small number
of patients that were included and, therefore, may have had lim-
ited power to detect differences. Moreover, immunogenetic stud-
ies suggested the inhibitory killer cell immunoglobulin-like
receptor (KIR) KIR2DL3 and group 1 HLA-C to be protective
against evolution of chronic HCV infection [3]. This association
is thought to be the result of weaker inhibitory signals generated
by KIR2DL3 as compared to KIR2DL1, which enables faster activa-
tion of KIR2DL3 expressing NK cells compared with those
expressing KIR2DL1 [17]. Of note, Alter and co-workers found sig-
niﬁcantly up-regulated expression of KIRs recognizing HLA-C
molecules in patients who cleared the virus and Amadei et al.
recently observed a trend toward a higher de-granulation activity
in KIR2DL3-positive NK cells from self-limited as compared with
chronically evolving infections [14]. Thus, increased frequencies
of NK cells expressing HLA-C-binding KIRs may be associated
with HCV clearance.
In addition, Alter et al. demonstrated that in the acute phase
lower frequencies of NK cells expressing the activating receptors
NKp30, NKp46, and NKG2D as well as a low proportion of
CD161+ NK cells were associated with a self-limited course of
infection.
As both direct and indirect stimulation of NK cells resulted in
down-regulation of the natural cytotoxicity receptors (NCRs),
NKp30, and NKp46, respectively, the authors concluded that early
activation of NK cells, marked by a loss of NCRs (and NKG2D, and
CD161)may predict spontaneous HCV clearance. A role of NK cells
in the control and clearance of HCV is further supported by
Pelletier et al.who observed a correlation between NK cell activity
and T cell activity in acute hepatitis C, suggesting a coordinated
innate and adaptive immune response to acute HCV infection
[13]. However, we must be careful not to jump to conclusions
and there are still many questions to be resolved.
Different NK cell subsets are characterized by speciﬁc expres-
sion patterns of chemokines receptors [18]. As these surface
molecules are critically involved in lymphocyte migration,
altered composition/phenotype of circulating NK cells may just
be the result of hepatic recruitment of speciﬁc NK cell subsets.
Moreover, intra-hepatic NK cells may behave differently to
peripheral blood NK cells due to the speciﬁc environment in
the liver. For instance, murine intra-hepatic NK cells have been
shown to be hypo-responsive as they displayed lower cytotoxic
activity and reduced IFN-c secretion but produced greater levels266 Journal of Hepatology 201of immuno-regulatory cytokines such as interleukin-10 than cir-
culating NK cells [19].
Thus, it would be important to analyze phenotype and func-
tion of intra-hepatic NK cell subsets in the acute phase of HCV
infection. However, due to ethical reasons these data will hardly
be obtained.
Alternatively, altered surface expression of NK cell receptors
in patients that subsequently clear the virus might be an epiphe-
nomenon of an effective anti-viral immune-response. Cytokines
such as IFN-a have been shown to effectively activate NK cells
and to affect the NK cell phenotype [10,20]. Thus, changes in
cytokine secretion by other immuno-competent cells might affect
NK cell receptor expression in early HCV infection.
Taken together there is clear evidence that phenotypical and
functional alterations of NK cells occur early in HCV infection,
suggesting that NK cells may play a role in HCV immunopatho-
genesis. However, much more has to be learnt to exactly deﬁne
the speciﬁc contribution of NK cells to the outcome of hepatitis C.Conﬂict of interest
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